Aclarion Inc. Gains 22.86%
Tue, Jul 12, 2022 at 08:30 PM
Aclarion Inc. (ACON:NASDAQ) soared at $1.01, representing a gain of 22.9%. On Tue, Jul 12, 2022, ACON:NASDAQ hit a New 2-Week High of $1.01. The stock appeared on our News Catalysts scanner on Wed, Jun 22, 2022 at 07:25 AM in the 'BIOTECH' category. From Wed, Jun 29, 2022, the stock recorded 37.50% Up Days and 33.33% Green Days
The stock spiked on Wed, Apr 27, 2022 at $4.05 with a volume of 15M+.
About Aclarion Inc. (ACON:NASDAQ)
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments.
Top 10 Gainers:
- Sharps Compliance Corp. (SMED:NASDAQ), 196.14%
- Canoo Inc. (GOEV:NASDAQ), 53.16%
- Rhythm Pharmaceuticals, Inc. (RYTM:NASDAQ), 42.22%
- Greenwich LifeSciences Inc (GLSI:NASDAQ), 38.98%
- Regional Health Properties, Inc. (RHE:NYSEMKT), 36.88%
- China Online Education Group (COE:NYSE), 32.84%
- Histogen Inc. (HSTO:NASDAQ), 27.46%
- Romeo Power Inc. Class A (RMO:NYSE), 26%
- Lucira Health Inc. (LHDX:NASDAQ), 24.28%
- Aclarion Inc. (ACON:NASDAQ), 22.86%